Bayer Intellectual Property Gmbh / Bayer Aktiengesellschaft opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Bayer Intellectual Property Gmbh / Bayer Aktiengesellschaft

Patent Number:
Title:
Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins
Applicant:
Opposition Date:
Jun 23, 2023
Patent Number:
Title:
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer
Opposition Date:
Apr 6, 2023
Patent Number:
Title:
System And Method For Plant Disease Detection Support
Applicant:
Opposition Date:
Dec 21, 2022
Patent Number:
Title:
High-Concentration Monoclonal Antibody Formulations
Applicant:
Opposition Date:
Jan 31, 2019
Patent Number:
Title:
Aqueous Agroformulation Comprising Suspended Pesticide, Cellulose Ether And Thickener
Applicant:
Opposition Date:
Dec 14, 2018
Patent Number:
Title:
Endoxifen Methods And Compositions
Opposition Date:
Oct 31, 2018
Patent Number:
Title:
Aqueous Coating Compositions
Opposition Date:
May 30, 2018
Patent Number:
Title:
Bioreactor And Bioprocessing Technique
Opposition Date:
Apr 25, 2018
Patent Number:
Title:
Methods For Inactivation Of Viruses And Bacteria In Cell Culture Media
Opposition Date:
Nov 9, 2017

Competitors of Bayer Intellectual Property Gmbh / Bayer Aktiengesellschaft

BASF SE

ASTELLAS PHARMA INC.

F. HOFFMANN-LA ROCHE AG

Want to track Bayer Intellectual Property Gmbh / Bayer Aktiengesellschaft?

Feel free to send us a message here and we will get back to you